These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 7782847

  • 1. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm.
    Kinugasa K, Kamata I, Hirotsune N, Tokunaga K, Sugiu K, Handa A, Nakashima H, Ohmoto T, Mandai S, Matsumoto Y.
    J Neurosurg; 1995 Jul; 83(1):34-41. PubMed ID: 7782847
    [Abstract] [Full Text] [Related]

  • 2. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM, Spetzler RF, Lee KS, Papadopoulos SM, Bovill E, Zimmerman RS, Bederson JB.
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [Abstract] [Full Text] [Related]

  • 3. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
    Findlay JM, Weir BK, Kassell NF, Disney LB, Grace MG.
    J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
    [Abstract] [Full Text] [Related]

  • 4. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases.
    Murayama Y, Malisch T, Guglielmi G, Mawad ME, Viñuela F, Duckwiler GR, Gobin YP, Klucznick RP, Martin NA, Frazee J.
    J Neurosurg; 1997 Dec; 87(6):830-5. PubMed ID: 9384391
    [Abstract] [Full Text] [Related]

  • 5. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
    Usui M, Saito N, Hoya K, Todo T.
    Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
    [Abstract] [Full Text] [Related]

  • 6. Use of intraventricular tissue plasminogen activator and Guglielmi detachable coiling for the acute treatment of casted ventricles from cerebral aneurysm hemorrhage: two technical case reports.
    Azmi-Ghadimi H, Heary RF, Farkas JE, Hunt CD.
    Neurosurgery; 2002 Feb; 50(2):421-4; discussion 424-5. PubMed ID: 11844282
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Ohman J, Servo A, Heiskanen O.
    J Neurosurg; 1991 Aug; 75(2):197-201. PubMed ID: 1906535
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms.
    Górski R, Zabek M, Jarmuzek P.
    Neurol Neurochir Pol; 2000 Aug; 34(6 Suppl):41-7. PubMed ID: 11452854
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage.
    Steinberg GK, Vanefsky MA, Marks MP, Adler JR, Koenig GH.
    Neurosurgery; 1994 May; 34(5):809-13; discussion 813-4. PubMed ID: 8052377
    [Abstract] [Full Text] [Related]

  • 14. Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling.
    Hall B, Parker D, Carhuapoma JR.
    Neurocrit Care; 2005 May; 3(2):153-6. PubMed ID: 16174886
    [Abstract] [Full Text] [Related]

  • 15. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
    Sasaki T, Ohta T, Kikuch H, Takakura K, Usui M, Kondoh A, Tanabe H, Nakamura J, Yamada K.
    No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM, Kassell NF, Weir BK, Haley EC, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW.
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [Abstract] [Full Text] [Related]

  • 17. Combined drug therapy with diltiazem, dextran, and hydrocortisone (DDH therapy) for late cerebral vasospasm after aneurysmal subarachnoid hemorrhage: assessment of efficacy and safety in an open clinical study.
    Kawano T, Kazekawa K, Nakashima S, Kohno H, Tanaka N, Honma T, Kaneko Y, Satoh K.
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):513-7. PubMed ID: 8520810
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY, Kostanian V, Rivera M, Lee KW, Chen CC, Nguyen TH.
    Cardiovasc Intervent Radiol; 2007 Sep; 30(4):675-87. PubMed ID: 17573553
    [Abstract] [Full Text] [Related]

  • 20. [Correlation of vasospasm with operative results in ruptured aneurysms].
    Nitta M, Nagai H, Hara M, Tanaka H, Shintani A, Takagi T, Hori H, Ito H, Maeda S.
    No Shinkei Geka; 1982 Aug; 10(8):823-9. PubMed ID: 7133303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.